Velodyne Lidar Experts to Address Perception Breakthroughs for Autonomous Vehicles at IDTechEx
The world’s largest event on emerging technologies, IDTechEx Show!, will feature presentations from two senior Velodyne Lidar, Inc. experts who will address the future of lidar technology. The discussions will focus on how lidar will enable advanced vehicle safety and performance for autonomous vehicles. More than 3,500 people from a wide range of disciplines, from end-user executives to manufacturers and system integrators, are expected to attend the event at the Santa Clara (Calif.) Convention Center on Nov. 14-15.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181108005503/en/
Anand Gopalan, Ph.D., Chief Technology Officer (CTO) at Velodyne Lidar, is presenting on lidar technology at the IDTechEx Show!. (Photo: Business Wire)
Velodyne Lidar’s Anand Gopalan, Ph.D., Chief Technology Officer (CTO) and Stephen Nestinger, Ph.D., Director of Mechanical Engineering, will lead conference sessions about the levels of lidar sensor performance and reliability required for autonomous vehicles to operate safely. Gopalan and Nestinger will review how Velodyne’s proven product line of lidar sensors enable autonomy and improve safety in lower-speed urban environments and at highway speeds. Additional discussion points will focus on Velodyne‘s continued status as the industry leader in the design and manufacture of lidar sensors, the essential components of self-driving cars. The sessions will also outline the company’s commitment to inventing and refining new technologies.
How Lidar is Shaping Our Autonomous Future
IDTechEx Show! attendees will hear Gopalan discuss lidar’s role and importance in autonomous perception. The session will also address various misconceptions about the current state of lidar technology and its future outlook.
“As the leader in lidar technology, Velodyne has a unique, bird's-eye view on where the autonomous mobility industry is headed in terms of the hardware requirements for perception. This session will explore why lidar is needed for level 4 and level 5 autonomous vehicles, and how lidar can vastly enhance the performance of level 2+ advanced driver-assistance systems (ADAS). It will also examine what lidar will and won’t be able to do in the future as the technology matures,” said Gopalan.
Gopalan’s session, titled “The Essential Role of Lidar Technology in Shaping Our Autonomous Future,” takes place on Nov. 15, from 8:40 a.m. to 9:00 a.m. in Grand Ballroom C.
At Velodyne Lidar, Gopalan is responsible for the advanced product and technology developments that are powering the company’s latest lidar products. He is a seasoned technology executive with experience building and leading worldwide engineering organizations for the development of products in consumer, networking, and enterprise domains.
Providing Precise Situational Awareness in a Range of Applications
Nestinger will discuss how Velodyne’s revolutionary sensing portfolio provides precise situational awareness for applications ranging from forest canopy surveying to autonomous vehicles and embeddable ADAS. The session will also address technological development towards the integration of additional sensing modalities that will enhance perception and save lives.
Nestinger’s session, titled “Illuminating the Perception Horizon with Multi-Modality 3D Lidar,” takes place on Nov. 14, from 5:40 p.m. to 6:00 p.m. in Grand Ballroom F.
Nestinger joined Velodyne Lidar in 2014 and has contributed to the design, development, and production of Velodyne’s world renowned lidar sensors. Before joining Velodyne Lidar, he was an Assistant Professor in the mechanical engineering department and robotics engineering program at the Worcester Polytechnic Institute.
About Velodyne Lidar
Founded in 1983 and headquartered in Silicon Valley, Velodyne is a technology company known worldwide for its real-time 3D lidar computing and software platforms. The company evolved after founder David Hall invented the HDL-64 Solid-State Hybrid lidar sensor in 2005. Since then, Velodyne Lidar, Inc. emerged as the unmatched market leader of real-time 3D vision systems used in a variety of commercial applications including autonomous vehicles, vehicle safety systems, mobile mapping, aerial mapping, and security. Its products range from the high-performance, surround view Ultra-Puck™ VLP-32, classic HDL-32/64 and cost-effective VLP-16, the new VLS-128, to the upcoming, hidden Velarray™. Velodyne’s rich suite of perception software and algorithms are the key enablers of its perception systems. Velodyne supports customers from offices in San Jose, Detroit, Frankfurt, and Beijing. For more information, visit http://www.velodynelidar.com.
Landis Communications for Velodyne Lidar, Inc.
David Cumpston, 415-359-2316
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Aroma Bit to Develop Smartphone Embeddable Ultra-compact Silicon CMOS Based Smell Sensor That Has Dog Nose Equivalent Resolution in 1mm Squared Die Size23.7.2019 04:30:00 EEST | Press release
Aroma Bit launched a new subsidiary to develop the next generation smell sensor based on silicon CMOS sensor substrate that are ultra-compact, high resolution and low cost. The technology is realized by applying Aroma Bit developed smell sensor receptor membrane technology to ultra-sensitive silicon CMOS based ion imaging sensor technology developed by professor Kazuaki Sawada at Toyohashi University of Technology and associated companies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190722005004/en/ Picture of 1mm squared die of silicon CMOS based smell sensor, with dog nose equivalent ~1,200 sensor pixels (Photo: Business Wire) Aroma Bit: http://www.aromabit.com Realizing smartphone embeddable smell sensor with dog nose equivalent ultra-high resolution smell sensor on only 1 millimeter square silicon die size Aroma Bit has developed and are currently selling a compact smell sensor that employs QCM or Quartz Crystal Micro
Logitech Delivers a Strong Start to Fiscal Year 2020 with Robust Sales and Profit Growth23.7.2019 04:00:00 EEST | Press release
Logitech International (SIX: LOGN) (Nasdaq: LOGI) today announced financial results for the first quarter of Fiscal Year 2020. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190722005781/en/ Logitech delivers a strong start to Fiscal Year 2020 with robust sales and profit growth. (Graphic: Business Wire) Q1 sales were $644 million, up 6 percent in US dollars and 9 percent in constant currency, compared to Q1 of the prior year. Q1 GAAP operating income grew 46 percent to $47 million, compared to $32 million in the same quarter a year ago. Q1 GAAP earnings per share (EPS) grew 17 percent to $0.27, compared to $0.23 in the same quarter a year ago. Q1 non-GAAP operating income grew 11 percent to $67 million, compared to $61 million in the same quarter a year ago. Q1 non-GAAP EPS grew 15 percent to $0.39, compared to $0.34 in the same quarter a year ago. Cash flow from operations was $37 million, compared to $12 million in the sa
Gilead Presents New Data on Biktarvy® for the Treatment of HIV in Women and in Virologically Suppressed Patients With Known Resistance22.7.2019 19:00:00 EEST | Press release
Gilead Sciences, Inc. (NASDAQ: GILD) today presented findings from two Phase 3 trials – a trial demonstrating the effectiveness of switching to Biktarvy (bictegravir 50mg/emtricitabine 200mg/tenofovir alafenamide 25mg tablets, B/F/TAF) in women, and a trial evaluating the potential for the single tablet regimen to be an effective treatment option in virologically suppressed patients with known resistance to nucleo(s)tide or non-nucleo(s)tide reverse transcriptase inhibitors (NRTIs or NNRTIs). The use of Biktarvy in patients with known drug resistance is investigational. These data were presented at the 10th International AIDS Society Conference on HIV Science (IAS 2019) being held in Mexico City. “These data presented at IAS provide new information about the treatment of HIV among women and patients with known drug resistance,” said Diana Brainard, MD, Senior Vice President, HIV and Emerging Viruses, Gilead Sciences. “The studies further demonstrate the potential for Biktarvy to be an
IBC Celebrates Young Talent in the Industry22.7.2019 18:36:00 EEST | Press release
The media, entertainment and technology industry is changing. Attitudes are shifting, the next generation is consuming content differently to any before them and diverse and exciting content is being created to meet that demand in innovative formats. Driving this change is a new wave of industry talent, honoured at IBC with the first IBC Young Pioneer Award. Recognising the brightest, newest talent in the industry, this award will go to someone who has made a real impact with their passion, ambition and commitment and is making an outstanding contribution to our industry. “What we were looking for in the shortlist was, most importantly, real talent, a stand-out individual making a real difference in the industry,” said David Levine, VP, Programming - Kids, Europe & Africa/UK & Ireland, The Walt Disney Co. Ltd and Chair of the Judging Panel. “But we were also looking for a lasting legacy, for the Young Pioneer to be a leader today and a media guru of the future.” The call for entries so
Gilead Presents Proof-of-Concept Data for GS-6207, a First-in-Class Capsid Inhibitor, in People Living With HIV22.7.2019 18:00:00 EEST | Press release
Gilead Sciences, Inc. (NASDAQ: GILD) today presented the first clinical data in people living with HIV on GS-6207, an investigational, novel, selective, first-in-class inhibitor of HIV capsid function. The Phase 1b data demonstrate the first proof of concept that HIV capsid inhibition can lead to significant declines in viral load in vivo. In addition, Gilead presented preclinical data demonstrating that resistance to GS-6207 in vitro did not lead to resistance to other classes of drugs used in the treatment of HIV. These data were presented at the 10th International AIDS Society Conference on HIV Science (IAS 2019) in Mexico City. GS-6207 is an investigational long-acting antiretroviral agent that can be delivered subcutaneously. GS-6207 recently received breakthrough therapy designation from the U.S. Food and Drug Administration (FDA) as a potential therapy for heavily treatment-experienced people living with multi-drug resistant HIV. GS-6207 acts in a novel way compared with current
Pacific Drilling Appoints James W. Harris as Chief Financial Officer22.7.2019 16:42:00 EEST | Press release
Pacific Drilling S.A. (NYSE: PACD), one of the world’s leading deepwater drilling contractors, today announced that Pacific Drilling’s Board has appointed James W. Harris to serve as the Company’s Senior Vice President and Chief Financial Officer. Mr. Harris replaces Mr. Johannes (John) P. Boots, who, as previously announced, mutually agreed with the Company to step down from his position to pursue other opportunities. Mr. Harris has more than 30 years of experience in the energy industry in a variety of financial leadership, strategic and business planning roles. He most recently served as Executive Vice President, Drilling & Subsea for Forum Energy Technologies, Inc., having previously served Forum as Chief Financial Officer for 12 years. Bernie Wolford, the Company’s Chief Executive Officer, stated, “We sincerely appreciate the many contributions that John has made during his nearly 10-year tenure with Pacific Drilling and we wish him all the best in his future endeavors.” “We are e
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom